BSC
RYTM icon

BOLTON SECURITIES CORPORATION’s Rhythm Pharmaceuticals RYTM Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.1K Buy
+300
New +$29.2K ﹤0.01% 1387
2025
Q3 		$30.3K Buy
+300
New +$27.9K ﹤0.01% 1284
2025
Q1 		$15.9K Buy
+300
New +$16.6K ﹤0.01% 1335

Other funds holding RYTM

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's RYTM Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Rhythm Pharmaceuticals (RYTM) in Q1 2026: 300 shares worth $26.1K. The stake represents ﹤0.01% of the portfolio and ranks #1387 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in RYTM as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in RYTM in Q1 2025 and has held it in 3 quarters since. The position peaked at $30.3K in Q3 2025. 288 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 300 shares of Rhythm Pharmaceuticals worth $26.1K as of Q1 2026.
  • Rhythm Pharmaceuticals was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1387 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's Rhythm Pharmaceuticals position peaked at $30.3K in Q3 2025.
  • 288 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.